DVA logo

DaVita (DVA)

Profile

Full Name

DaVita Inc.

Ticker Symbol

DVA

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

October 31, 1995

Indexes

S&P 500

Website

http://www.davita.com

Employees

76000

Key Details

Price

$146.01

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$12.82B(+5.56% YoY)

Annual EPS

$10.73(+44.61% YoY)

PE Ratio

13.59

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$146.01
DVA price is $146.01

Price All-time High

$178.39
DVA price is currently -18.15% below its historical high of $178.39

Price Today Change

+0.77%
DVA price is up +0.77% today

Price YTD Change

-1.68%
DVA price is down -1.68% since January 1st

Price 1-year Change

+8.16%
DVA price is up +8.16% year-on-year

Price 3-year Change

+27.91%
DVA price is up +27.91% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$11.68B
DVA market capitalization is $11.68 billion

Market Cap 3-year Change

+7.45%
DVA market capitalization is up +7.45% over the past 3 years

Market Cap All-time High

$18.11B
DVA market capitalization is currently -35.50% below its historical high of $18.11 billion

Market Cap Sector Rank

93.52%
DVA market capitalization is higher than 93.52% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-8.78%
DVA shares outstanding is down -8.78% year-on-year

Shares Outstanding 3-Year Change

-16%
DVA shares outstanding is down -16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
DVA beta is 0.43

200-day SMA

$153.19
DVA price is currently -4.69% below its 200-day simple moving average

50-day SMA

$156.73
DVA price is currently -6.84% below its 50-day simple moving average

RSI

56.07
DVA 14-day relative strength index is 56.07

Volume

0.70
DVA 30-day relative volume is 0.70

ATR

$3.84
DVA average true range is $3.84

10-day Historical Volatility

17.92%
DVA 10-day historical volatility is 17.92%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$12.82B
DVA annual revenue is $12.82 billion

Revenue Analysts Estimate

$13.44B
DVA annual revenue is currently -4.68% lower than the consensus analysts' forecast

Revenue 1-year Change

+5.56%
DVA annual revenue is up +5.56% year-on-year

Revenue Sector Rank

95.11%
DVA annual revenue is higher than 95.11% of companies in Healthcare sector

EPS

EPS

$10.73
DVA annual earnings per share is $10.73

EPS Analysts Estimate

$11.06
DVA annual earnings per share is currently -3.01% lower than the consensus analysts' forecast

EPS 1-year Change

+44.61%
DVA annual earnings per share is up +44.61% year-on-year

EPS Sector Rank

98.15%
DVA annual earnings per share is higher than 98.15% of companies in Healthcare sector

Profit

Gross Profit

$4.22B
DVA annual gross profit is $4.22 billion

Gross Margin

32.91%
DVA annual gross profit margin is 32.91%

Operating Profit

$1.95B
DVA annual operating income is $1.95 billion

Operating Margin

15.25%
DVA annual operating profit margin is 15.25%

Net Income

$936.34M
DVA annual net profit is $936.34 million

Net Margin

7.31%
DVA annual net profit margin is 7.31%

Expenses

Total Expenses

$10.86B
DVA annual total expenses is $10.86 billion

Operating Expenses

$2.26B
DVA annual total operating expenses is $2.26 billion

Cost Of Goods Sold

$8.60B
DVA annual cost of goods sold is $8.60 billion

Selling, General & Administrative Expenses

$1.54B
DVA annual SGA is $1.54 billion

Depreciation And Amortization

$723.86M
DVA annual depreciation & amortization is $723.86 million

Interest Expense

$470.47M
DVA annual interest expense is $470.47 million

Income Tax

$279.66M
DVA annual income tax is $279.66 million

EBIT & EBITDA

EBIT

$2.00B
DVA annual earnings before interest & taxes is $2.00 billion

EBITDA

$2.72B
DVA annual EBITDA is $2.72 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$17.29B
DVA annual total assets is $17.29 billion

Non Current Assets

$13.54B
DVA annual long term assets is $13.54 billion

Current Assets

$3.75B
DVA annual total current assets is $3.75 billion

Cash And Cash Equivalents

$794.93M
DVA annual cash & cash equivalents is $794.93 million

Accounts Receivable

$2.15B
DVA annual accounts receivable is $2.15 billion

Inventory

$134.56M
DVA annual inventory is $134.56 million

Liabilities

Total Liabilities

$15.19B
DVA annual total liabilities is $15.19 billion

Long Term Liabilities

$12.22B
DVA annual total long term liabilities is $12.22 billion

Current Liabilities

$2.97B
DVA annual total current liabilities is $2.97 billion

Accounts Payable

$547.20M
DVA annual accounts payable is $547.20 million

Debt

Total Debt

$12.07B
DVA annual total debt is $12.07 billion

Total Debt 1-year Change

+8.55%
DVA annual total debt is up +8.55% year-on-year

Long Term Debt

$11.39B
DVA annual long term debt is $11.39 billion

Short Term Debt

$681.28M
DVA annual short term debt is $681.28 million

Equity & Capital

Shareholders Equity

$121.12M
DVA annual stockholders equity is $121.12 million

Book Value

$121.12M
DVA annual book value is $121.12 million

Retained Earnings

$1.53B
DVA annual retained earnings is $1.53 billion

Working Capital

$772.66M
DVA annual working capital is $772.66 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$2.02B
DVA annual cash flow from operations is $2.02 billion

Cash From Operations 1-year Change

-1.8%
DVA annual cash flow from operations is down -1.8% year-on-year

Cash From Investing

-$771.43M
DVA annual cash flow from investing activities is -$771.43 million

Cash From Investing 1-year Change

+0.05%
DVA annual cash flow from investing activities is up +0.05% year-on-year

Cash From Financing

-$816.94M
DVA annual cash flow from financing activities is -$816.94 million

Cash From Financing 1-year Change

+30.21%
DVA annual cash flow from financing activities is up +30.21% year-on-year

CAPEX

CAPEX

$555.44M
DVA annual capital expenditures is $555.44 million

CAPEX 1-year Change

-2.21%
DVA annual capital expenditures is down -2.21% year-on-year

Free Cash Flow

Free Cash Flow

$1.47B
DVA annual free cash flow is $1.47 billion

Free Cash Flow 1-year Change

-1.64%
DVA annual free cash flow is down -1.64% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

32.91%
DVA annual gross profit margin is 32.91%

Operating Margin

15.25%
DVA annual operating profit margin is 15.25%

Net Margin

7.31%
DVA annual net profit margin is 7.31%

ROA & ROE

ROA

5.48%
DVA annual return on assets is 5.48%

ROE

38.73%
DVA annual return on equity is 38.73%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

13.59
DVA price to earnings ratio is 13.59

PE Ratio Sector Rank

20.39%
DVA price to earnings ratio is higher than 20.39% of companies in Healthcare sector

PB Ratio

PB Ratio

96.44
DVA price to book ratio is 96.44

PB Ratio Sector Rank

99.34%
DVA price to book ratio is higher than 99.34% of companies in Healthcare sector

PS Ratio

PS Ratio

0.91
DVA price to sales ratio is 0.91

PS Ratio Sector Rank

25.26%
DVA price to sales ratio is higher than 25.26% of companies in Healthcare sector

Enterprise value

Enterprise Value

$22.95B
DVA enterprise value is $22.95 billion

Enterprise Value Sector Rank

95.21%
DVA enterprise value is higher than 95.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

8.42
DVA EV/EBITDA is 8.42

EV/EBITDA Sector Rank

80.49%
DVA EV/EBITDA is higher than 80.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

1.26
DVA annual current ratio is 1.26

Quick Ratio

1.21
DVA annual quick ratio is 1.21

Leverage

Debt To Equity

77.99
DVA annual debt to equity ratio is 77.99

Interest Coverage Ratio

4.25
DVA annual interest coverage ratio is 4.25

Risk & Stability

Piotroski F-Score

8
DVA piotroski f-score is 8

Altman Z-Score

1.76
DVA altman z-score is 1.76

Analyst ratings

Recent major analysts updates

Feb 18, 25 Barclays
Equal-Weight
Oct 31, 24 Barclays
Equal-Weight
Oct 7, 24 Truist Securities
Hold
Aug 20, 24 Truist Securities
Hold
Aug 8, 24 UBS
Buy
Aug 7, 24 B of A Securities
Underperform
Jul 24, 24 TD Cowen
Hold
May 15, 24 Truist Securities
Hold
May 6, 24 Barclays
Equal-Weight
Mar 6, 24 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

GMAB logo
Genmab A/S (GMAB)
ALGN logo
Align Technology (ALGN)
UHS logo
Universal Health Services (UHS)
INCY logo
Incyte (INCY)
COR logo
Cencora (COR)
SNN logo
Smith & Nephew (SNN)
THC logo
Tenet Healthcare (THC)
ILMN logo
Illumina (ILMN)
RDY logo
Dr Reddys Laboratories Limited (RDY)
  • What is the ticker symbol for DaVita?
  • Does DaVita pay dividends?
  • What sector is DaVita in?
  • What industry is DaVita in?
  • What country is DaVita based in?
  • When did DaVita go public?
  • Is DaVita in the S&P 500?
  • Is DaVita in the NASDAQ 100?
  • Is DaVita in the Dow Jones?
  • When was DaVita's last earnings report?
  • When does DaVita report earnings?
  • Should I buy DaVita stock now?

What is the ticker symbol for DaVita?

The ticker symbol for DaVita is NYSE:DVA

Does DaVita pay dividends?

No, DaVita does not pay dividends

What sector is DaVita in?

DaVita is in the Healthcare sector

What industry is DaVita in?

DaVita is in the Medical Care Facilities industry

What country is DaVita based in?

DaVita is headquartered in United States

When did DaVita go public?

DaVita's initial public offering (IPO) was on October 31, 1995

Is DaVita in the S&P 500?

Yes, DaVita is included in the S&P 500 index

Is DaVita in the NASDAQ 100?

No, DaVita is not included in the NASDAQ 100 index

Is DaVita in the Dow Jones?

No, DaVita is not included in the Dow Jones index

When was DaVita's last earnings report?

DaVita's most recent earnings report was on Feb 13, 2025

When does DaVita report earnings?

The next expected earnings date for DaVita is May 2, 2025

Should I buy DaVita stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page